A: UC San Diego is collaborating with Deerfield, an investment firm dedicated to advancing healthcare, to create Poseidon Innovation. This partnership will accelerate the translation of research in UC San Diego faculty laboratories into clinical therapeutics. Poseidon Innovation is a Deerfield company that will support UC San Diego’s innovative translational research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development.
Poseidon will fund projects with the aim of establishing novel, life-saving therapeutics to cure diseases.
Through Poseidon, Deerfield has committed up to $65 million in initial funding to support promising UC San Diego translational research. Deerfield will provide operational support, and may make additional capital investments into spin-off companies emerging from Poseidon projects that show commercial potential.
A: Principal Investigators who are full-time employees of UC San Diego or who have a faculty appointment at UC San Diego and are subject to UC San Diego’s policies regarding the conduct of research and ownership of intellectual property.
A: To submit an application, please visit the Request for Proposal (RFP) page on the Poseidon website.
A: There will be two calls for proposal each year, with the exception of only one call in 2018.
A: No. Re-submissions may be made for all projects based on the constructive feedback provided by the Alliance Manager and the JSC.
A: No. We welcome applications from all therapeutic areas.